These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36619167)

  • 1.
    Metwally AA; Nayel AA; Hathout RM
    Front Mol Biosci; 2022; 9():1042720. PubMed ID: 36619167
    [No Abstract]   [Full Text] [Related]  

  • 2. Machine learning-driven QSAR models for predicting the mixture toxicity of nanoparticles.
    Zhang F; Wang Z; Peijnenburg WJGM; Vijver MG
    Environ Int; 2023 Jul; 177():108025. PubMed ID: 37329761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do we need different machine learning algorithms for QSAR modeling? A comprehensive assessment of 16 machine learning algorithms on 14 QSAR data sets.
    Wu Z; Zhu M; Kang Y; Leung EL; Lei T; Shen C; Jiang D; Wang Z; Cao D; Hou T
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33313673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient predictions of cytotoxicity of TiO
    Banerjee A; Kar S; Pore S; Roy K
    Nanotoxicology; 2023 Feb; 17(1):78-93. PubMed ID: 36891579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial QSAR of ambergris fragrance compounds.
    Kovatcheva A; Golbraikh A; Oloff S; Xiao YD; Zheng W; Wolschann P; Buchbauer G; Tropsha A
    J Chem Inf Comput Sci; 2004; 44(2):582-95. PubMed ID: 15032539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of different QSAR approaches to modeling CYP450 1A2 inhibition.
    Novotarskyi S; Sushko I; Körner R; Pandey AK; Tetko IV
    J Chem Inf Model; 2011 Jun; 51(6):1271-80. PubMed ID: 21598906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cheminformatics Approach to Gene Silencing: Z Descriptors of Nucleotides and SVM Regression Afford Predictive Models for siRNA Potency.
    Ebalunode JO; Zheng W
    Mol Inform; 2010 Dec; 29(12):871-81. PubMed ID: 27464351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
    Kosugi Y; Hosea N
    Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative structure-activity relationship model for prediction of cardiotoxicity of chemical components in traditional Chinese medicines].
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):551-556. PubMed ID: 28628163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm.
    Wang W; Feng S; Ye Z; Gao H; Lin J; Ouyang D
    Acta Pharm Sin B; 2022 Jun; 12(6):2950-2962. PubMed ID: 35755271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR--how good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets.
    Gedeck P; Rohde B; Bartels C
    J Chem Inf Model; 2006; 46(5):1924-36. PubMed ID: 16995723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.
    Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR
    ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An automated framework for QSAR model building.
    Kausar S; Falcao AO
    J Cheminform; 2018 Jan; 10(1):1. PubMed ID: 29340790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial QSAR modeling of P-glycoprotein substrates.
    de Cerqueira Lima P; Golbraikh A; Oloff S; Xiao Y; Tropsha A
    J Chem Inf Model; 2006; 46(3):1245-54. PubMed ID: 16711744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico prediction of major drug clearance pathways by support vector machines with feature-selected descriptors.
    Toshimoto K; Wakayama N; Kusama M; Maeda K; Sugiyama Y; Akiyama Y
    Drug Metab Dispos; 2014 Nov; 42(11):1811-9. PubMed ID: 25128502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined
    Maleckar MM; Myklebust L; Uv J; Florvaag PM; Strøm V; Glinge C; Jabbari R; Vejlstrup N; Engstrøm T; Ahtarovski K; Jespersen T; Tfelt-Hansen J; Naumova V; Arevalo H
    Front Physiol; 2021; 12():745349. PubMed ID: 34819872
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
    Ventura C; Latino DA; Martins F
    Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico development, validation and comparison of predictive QSAR models for lipid peroxidation inhibitory activity of cinnamic acid and caffeic acid derivatives using multiple chemometric and cheminformatics tools.
    Mitra I; Saha A; Roy K
    J Mol Model; 2012 Aug; 18(8):3951-67. PubMed ID: 22434311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Multiprognostic Index Domain Scores, Clinical Data, and Machine Learning to Improve 12-Month Mortality Risk Prediction in Older Hospitalized Patients: Prospective Cohort Study.
    Woodman RJ; Bryant K; Sorich MJ; Pilotto A; Mangoni AA
    J Med Internet Res; 2021 Jun; 23(6):e26139. PubMed ID: 34152274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.